Skip to main content
Caplight Logo









Amplifye

Amplifye

Private
Davis, CaliforniaHealthcare & Life Scienceshttps://amplifye.co/

Last Round

Series A

Jul 15, 2024

Total Funding Raised

$18.4M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Amplifye is a biotechnology company that develops proprietary protease enzymes using artificial intelligence and computational protein design to enhance protein digestion and nutrient absorption.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, D2C Brands, Sports & Fitness

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Infrastructure

Keywords

enzyme engineeringcomputational protein designprotein digestionbioavailabilityprecision fermentationenzyme supplementbio-designsynthetic biologynutraceuticalspet nutritionlivestock feedamino acid absorptionbiotech platformprotein optimizationgut health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplifye Comparables

Compare Amplifye with similar companies based on industry and business-model similarity.

Amplifye comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BiOptimizers
78%
Innophos
72%
International Flavors & Fragrances Inc.
62%

Amplifye Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJul 15, 2024
SeedMay 12, 2022

Key People

Founding team and executive leadership

Wilson Mak

Chief Technology Officer

Executive Team

Amplifye Investors

Notable investors and investment history

Amplifye investors
InvestorRounds
The March FundSeed, Series A
Astanor VenturesSeed, Series A
UC InvestmentsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 37% MoM.

  • Apr 15, 2025

    Grew 29% QoQ, from 14 to 18 employees.

Amplifye Filings

Explore SEC and related filing metadata, where available.

Amplifye filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amplifye's valuation, stock price, and market status.

Is Amplifye a public or private company?

Amplifye is a private company.

What is the current stock price of Amplifye?

Amplifye is a private company with no public stock price. No recent secondary market data is available.

How much is Amplifye worth (valuation)?

Valuation information for Amplifye is not publicly available.

Can I buy Amplifye stock?

Amplifye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amplifye's last funding round?

Amplifye's most recent funding round was Series A on July 15, 2024.

Who are the main investors in Amplifye?

Key investors in Amplifye include The March Fund, Astanor Ventures, UC Investments.

Will Amplifye IPO soon?

No public IPO plans have been announced for Amplifye.

How can I track Amplifye secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amplifye's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDavis, California
Employee Range17
Year Founded2019
Last FundingJul 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?